Close Menu

The Scan

Watching the Changes

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.

CMS Letter to Orig3n

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

And After the Test

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

New Scientist reports that a new genetic analysis suggests some saber-toothed cats may have lived in packs and been fast runners.

Almost As Good

A small study has found that a rapid test for SARS-CoV-2 works about as well as a PCR test, according to the New York Times.

New OA Model

PLOS is piloting a new model under which research institutions pay a flat fee for its researchers to publish in its journals, Science reports.

In Science this week: honey bees recognize colony mates by their gut microbiomes, and more.

Back in 5

Reuters reports University of Oxford researchers have developed a test for SARS-CoV-2 that can return results in five minutes.

Suit Over Pay

Five tenured Rutgers University professors are suing the school over pay disparities, according to the New York Times

"Dangerous" Proposal

The Washington Post reports that a herd immunity proposal has found a receptive audience at the White House to the dismay of most scientists.

In Nature this week: Akita method to predict genome folding based DNA sequence data, and more.

The Wall Street Journal reports clinical labs are grappling with staffing shortages, an issue exacerbated by the pandemic.

Researchers have linked three common gene variants to severe COVID-19 risk, Science reports.

All in One Spot

Nature News reports that a new initiative aims to make the abstracts of scientific papers accessible at a central site.

In Genome Biology this week: graph mapping-based approach to find indels in ancient DNA, tool to analyze chromatin interaction data, and more.

Again?

A genomic analysis indicates a Nevada man has been infected with SARS-CoV-2 twice, CNBC reports.

A Different Pause

Stat News reports Johnson & Johnson has paused its SARS-CoV-2 vaccine trial due to an unexplained illness affecting a study participant.

The Associated Press reports the trial of a Greek man accused of the rape and murder of a US researcher has begun.

In PNAS this week: characterization of diarrhea-causing swine coronavirus, metabolic differences in models with TP53 variant, and more.

China has joined the World Health Organization-led SARS-CoV-2 vaccine effort, NPR reports.

Pages

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.